Could a simple MRI and blood test predict moyamoya before it strikes?

NCT ID NCT07517354

Recruiting now Knowledge-focused Sponsor: Beijing Tiantan Hospital Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is looking at families where someone has moyamoya disease, a rare condition that narrows brain arteries and raises stroke risk. Researchers want to find early warning signs in first-degree relatives using advanced MRI scans and biological samples like blood and saliva. The goal is to create a screening tool to catch the disease early, before symptoms start. The study will follow 700 people for three years.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could lead to a simple screening method to detect moyamoya disease early in family members before symptoms appear.
What could go wrong: This is an observational study, not a treatment trial. It may not find clear markers, and results may take years to apply in practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MOYAMOYA DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Moyamoya disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MOYAMOYA DISEASE

Contacts and locations

Locations

Beijing Hospital
RECRUITING

Beijing, Beijing Municipality, 100730, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.